Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatments for people who use anabolic androgenic steroids: a scoping review
Geoff Bates, Marie Claire Van Hout, Joseph Tay Wee Teck, et al.
Harm Reduction Journal (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review
Giuseppe Albano, Francesco Amico, Giuseppe Cocimano, et al.
Healthcare (2021) Vol. 9, Iss. 1, pp. 97-97
Open Access | Times Cited: 132
Androgen Misuse and Abuse
David J. Handelsman
Endocrine Reviews (2021) Vol. 42, Iss. 4, pp. 457-501
Open Access | Times Cited: 64
Fake anabolic androgenic steroids on the black market – a systematic review and meta-analysis on qualitative and quantitative analytical results found within the literature
Raphael Magnolini, Luis Falcato, Alessio Cremonesi, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 45
“I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm
Luke Cox, Timothy Piatkowski, Jim McVeigh
Drugs Education Prevention and Policy (2024), pp. 1-13
Open Access | Times Cited: 16
Prevalence of anabolic steroid users seeking support from physicians: a systematic review and meta-analysis
Julio Mario Xerfan do Amaral, Andreas Kimergård, Paolo Deluca
BMJ Open (2022) Vol. 12, Iss. 7, pp. e056445-e056445
Open Access | Times Cited: 25
Anabolic Androgenic Steroid Use Patterns and Steroid Use Disorders in a Sample of Male Gym Visitors
Tjeerd de Zeeuw, Tibor M. Brunt, Jan van Amsterdam, et al.
European Addiction Research (2023) Vol. 29, Iss. 2, pp. 99-108
Open Access | Times Cited: 16
Health service engagement, side effects and concerns among men with anabolic-androgenic steroid use: a cross-sectional Norwegian study
Hans Christian Bordado Henriksen, Ingrid Amalia Havnes, Marie Lindvik Jørstad, et al.
Substance Abuse Treatment Prevention and Policy (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 13
“You Could Try This Compound, but it Might Send You nuts”: How Steroid Suppliers Perceive the Underground Market and Their ‘Hybrid’ Role within It
Timothy Piatkowski, Steve Vigorous, Luke Cox, et al.
Deviant Behavior (2024), pp. 1-12
Open Access | Times Cited: 5
The ethics of enhancement among image and performance enhancing drug coaches
Timothy Piatkowski, Luke Cox, Rick Collins
Health Sociology Review (2024), pp. 1-15
Open Access | Times Cited: 4
Community pharmacy’s role in dispensing androgens and supporting harm reduction amid current policy dilemmas
Timothy Piatkowski, Lkhagvadulam Ayurzana, Michelle A. King, et al.
Substance Abuse Treatment Prevention and Policy (2025) Vol. 20, Iss. 1
Open Access
How the love of muscle can break a heart: Impact of anabolic androgenic steroids on skeletal muscle hypertrophy, metabolic and cardiovascular health
Deaglan McCullough, Richard Webb, Kevin Enright, et al.
Reviews in Endocrine and Metabolic Disorders (2020) Vol. 22, Iss. 2, pp. 389-405
Open Access | Times Cited: 31
Performance and image enhancing drug interventions aimed at increasing knowledge among healthcare professionals (HCP): reflections on the implementation of the Dopinglinkki e-module in Europe and Australia in the HCP workforce
Amanda Atkinson, Katinka van de Ven, M Cunningham, et al.
International Journal of Drug Policy (2021) Vol. 95, pp. 103141-103141
Open Access | Times Cited: 27
Looking Beyond the Provision of Injecting Equipment to People Who Use Anabolic Androgenic Steroids: Harm Reduction and Behavior Change Goals for UK Policy
Geoff Bates, Jim McVeigh, Conan Leavey
Contemporary Drug Problems (2021) Vol. 48, Iss. 2, pp. 135-150
Open Access | Times Cited: 26
Harm reduction in the Enhanced Games: Can performance enhancing drugs be ‘safe’?
Martin Chandler, Ian D. Boardley
Performance Enhancement & Health (2025) Vol. 13, Iss. 3, pp. 100341-100341
Open Access
Aggression and Psychological Distress in Male and Female Anabolic-Androgenic Steroid Users: A Multigroup Latent Class Analysis
Razieh Chegeni, Guy Notelaers, Ståle Pallesen, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 23
Common symptoms associated with usage and cessation of anabolic androgenic steroids in men
Aditi Sharma, Bonnie Grant, Heraa Islam, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2022) Vol. 36, Iss. 5, pp. 101691-101691
Open Access | Times Cited: 16
Stigma and the Use of Anabolic Androgenic Steroids by Men in the United Kingdom
Jim McVeigh, Geoff Bates
Springer eBooks (2022), pp. 121-146
Closed Access | Times Cited: 14
The Impact of the COVID-19 Pandemic on Male Strength Athletes Who Use Non-prescribed Anabolic-Androgenic Steroids
Barnaby N. Zoob Carter, Ian D. Boardley, Katinka van de Ven
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 17
Harm reduction strategies for androgen users: providing appropriate support and improving engagement with healthcare
Geoff Bates, Scott T.C. Shepherd, Jim McVeigh
Current Opinion in Endocrinology Diabetes and Obesity (2021) Vol. 28, Iss. 6, pp. 630-635
Open Access | Times Cited: 17
Cardiac Complications of Common Drugs of Abuse: Pharmacology, Toxicology, and Management
Luke R. Gagnon, Chandu Sadasivan, Kevin Perera, et al.
Canadian Journal of Cardiology (2021) Vol. 38, Iss. 9, pp. 1331-1341
Closed Access | Times Cited: 17
Impact of an educational flyer and sensitization on performance-enhancement attitudes of bodybuilders in United Arab Emirates
Dixon Thomas, Adhnan Abdul Shabeek, Hala Ahmed, et al.
F1000Research (2024) Vol. 12, pp. 208-208
Open Access | Times Cited: 2
Attitudes of anabolic steroid users and non-users towards general practitioners in the United Kingdom
Andrew Richardson, Joseph Kean, Laura Fleming, et al.
Performance Enhancement & Health (2024), pp. 100304-100304
Open Access | Times Cited: 2
‘Sustaining masculinity’: a scoping review of anabolic androgenic steroid use by older males
Evelyn Hearne, Amanda Atkinson, Ian D. Boardley, et al.
Drugs Education Prevention and Policy (2022) Vol. 31, Iss. 1, pp. 27-53
Open Access | Times Cited: 11
Two sides of the same coin: A qualitative exploration of experiential and perceptual factors which influence the clinical interaction between physicians and Anabolic-Androgenic Steroid using patients in the UK
Neha Prasad Ainsworth, Sam N. Thrower, Andrea Petróczi
Emerging Trends in Drugs Addictions and Health (2022) Vol. 2, pp. 100033-100033
Open Access | Times Cited: 9
A study to demonstrate the potential of Anabolic Androgen Steroid to activate oxidative tissue damage, nephrotoxicity and decline endogenous antioxidant system in renal tissue of Adult Wistar Rats
Adejoke Elizabeth Memudu, Gambo A. Dongo
Toxicology Reports (2023) Vol. 10, pp. 320-326
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top